英科醫療(300677.SZ)2020年度淨利潤升3829.56%至70.07億元 擬10轉5派30元
格隆匯 3 月 15日丨英科醫療(300677.SZ)發佈2020年年度報吿,實現營業收入138.37億元,同比增長564.29%;歸屬於上市公司股東的淨利潤70.07億元,同比增長3829.56%;歸屬於上市公司股東的扣除非經常性損益的淨利潤70.06億元,同比增長4045.04%;基本每股收益21.98元,擬每10股派發現金紅利30元(含税),以資本公積金向全體股東每10股轉增5股。經營活動產生的現金流量淨額85.90億元,同比增長2505.62%。
公司是一家立足中國的綜合型醫療護理產品供應商,業務遍及全球。自成立以來,始終以客户需求為導向,致力於為全球醫療行業、工業、服務業以及個人提供優質的醫療用品和服務。公司總部設在山東淄博,主營業務涵蓋個人防護、康復護理、其他產品三大板塊,主要產品包括一次性手套、輪椅、冷熱敷、電極片等多種類型的護理產品,產品廣泛應用於醫療機構、養老護理機構、家庭日用及其他相關行業。經過多年的發展,公司已成為全球領先的醫療耗材供應商之一。
一次性手套是公司當前核心業務,在中國及全球有着卓越的市場佔有率,無論是創新自動化生產設施、專業知識還是先進製作工藝,在行業中都有着顯著的領先優勢。目前公司在國內擁有安徽淮北、山東青州、山東淄博三大生產基地,同時在江西九江、安徽安慶、湖南臨湘、河南商丘,以及海外越南有產能佈局。
公司大部分產品通過出口銷售到全球各地,主要產品遠銷美洲、歐洲、亞洲、非洲、大洋洲的120多個國家和地區,在全球範圍內服務約9600家客户。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.